Technical Analysis for ABIO - ARCA biopharma, Inc.
|Grade||Last Price||% Change||Price Change|
ABIO closed down 2.02 percent on Friday, July 21, 2017, on 2.15 times normal volume. It was able to find support at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
Trend Table & Recent Alerts
|Weak or Absent||Down||Up||Down|
|See historical ABIO trend table...|
|Date||Alert Name||Type||% Chg|
|Jul 21||50 DMA Support||Bullish||0.00%|
|Jul 21||200 DMA Resistance||Bearish||0.00%|
|Jul 21||Non-ADX 1,2,3,4 Bullish||Bullish Swing Setup||0.00%|
|Jul 20||200 DMA Resistance||Bearish||-2.02%|
|Jul 20||Narrow Range Bar||Range Contraction||-2.02%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.
Is ABIO a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ABIO news...
|52 Week High||3.21|
|52 Week Low||2.15|
|200-Day Moving Average||2.4827|
|50-Day Moving Average||2.4039|
|20-Day Moving Average||2.4613|
|10-Day Moving Average||2.4975|
|Average True Range||0.1175|
|Chandelier Exit (Long, 3 ATRs)||2.3575|
|Chandelier Exit (Short, 3 ATRs)||2.7025|
|Upper Bollinger Band||2.637|
|Lower Bollinger Band||2.2856|
|Percent B (%b)||0.4|
|MACD Signal Line||0.0254|